GeneralConnection.com ➔ Dictionary
Dictionary Search

factor ix

Synonyms

Noun

1. Christmas factor

2. factor IX, coagulation factor, clotting factor

Usage
Hemophilia B Gene Therapy Demonstrates Long-Term Efficacy and Safety - Hematology Advisor
Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later - MedPage Today
Gene Therapy for Hemophilia B Demonstrates Long-Term Success - Technology Networks
Clinical trial: Hemophilia B, (NCT06611436) - CRISPR Medicine - CRISPR Medicine News
Hemophilia B gene therapy demonstrates long-term success - EurekAlert!
Haemophilia gene therapy patients thriving over a decade after treatment | UCL News - UCL - UCL - London's Global University
A novel snake venom C-type lectin-like protein modulates blood coagulation by targeting von Willebrand factor and coagulation factor IX - Nature
'Freedom From the Need': A Pharmacist's Journey From Constant Hemophilia B Treatment to Gene Therapy - Pharmacy Times
Idelvion: Cost, dosage, side effects, uses, interactions, and more - Medical News Today
Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with hemophilia A or B - News-Medical
Multiyear Follow-up Study Shows Positive Results for Hemophilia B Gene Therapy - Managed Healthcare Executive
Ixinity (trenonacog alfa) for hemophilia - Hemophilia News Today
What is the infected blood scandal and how much compensation will victims get? - BBC
VisualAbstract: Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B is Superior to Prophylaxis - 2 Minute Medicine
Haemophilia B gene therapy safe, effective for long-term: Study - deshsewak.org
Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and ALPROLIX® at ASH Annual Meeting - Biogen
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Today
Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024 - Business Wire
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis - MedPage Today
Pfizer to Discontinue Its Hemophilia B Gene Therapy - MedPage Today
Discovering cancer stem-like molecule, nuclear factor I X, using spatial transcriptome in gastric cancer - Wiley Online Library
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa - PNAS
As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay - Fierce Pharma
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapy - Frontiers
Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab - American Heart Association Journals
Hemophilia B Market Size to Reach USD 24.7 Billion by 2035, Impelled by Advancements in Gene Therapy - BioSpace
Clinical trial: Hemophilia B, (NCT06379789) - CRISPR Medicine - CRISPR Medicine News
Hemgenix shows efficacy among haemophilia B patients - PharmaTimes
Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice - Nature
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors - BioSpace
Fig. 4. Intragenic polymorphisms of factor IX gene used for carrier... - researchgate.net
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B - PR Newswire
Development of SerpinPC as treatment for hemophilia halted by Centessa - Hemophilia News Today
The incidence of hemophilia disease as caused by impaired blood... - researchgate.net
CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix - PMLiVE
FDA Approves Pfizer's Hympavzi for Hemophilia A, B - Medscape
Hemophilia B Gene Therapy Achieves Sustained Benefit Over 4 Years - HCPLive
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B - Wiley Online Library
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant - The New England Journal of Medicine
Get easily bruised? It may be due to haemophilia B - Healthshots
uniQure successfully defends haemophilia gene therapy patent against Pfizer - JUVE Patent
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product - Nature
Recombinant factor IX Fc for the treatment of hemophilia B - Ljung - 2024 - European Journal of Haematology - Wiley Online Library
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
Haemophilia B: The Rare Disorder That Might Be Hiding Behind Your Bruises - OnlyMyHealth
Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies - Nature
Systemic delivery of factor IX messenger RNA for protein replacement therapy - PNAS
Mechanism of action for heparins. LMWH—low molecular weight heparin;... - researchgate.net
U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B - BioMelbourne Network
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
CSL Behring Announces Positive Reimbursement Decision in Canada for HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - BioSpace
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI - PNAS
Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B - The New England Journal of Medicine
Haemophilia B: My £2.6m blood has 'cured' my haemophilia - BBC
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin - Nature
A 'transformative' gene therapy for haemophilia B - The Week
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector - Nature
Fig. 3. Deficiencias de Factor VIII (Hemofilia A) y Factor IX (Hemofilia B) - researchgate.net
Diagram of factor IX (FIX) gene and protein structure. (A) FIX gene... - researchgate.net
World's most expensive hemophilia gene therapy Hemgenix may land in Korea soon: report - koreabiomed.com
Coagulation cascade and Factor XI inhibitors. FXI(a), factor XI(a);... - researchgate.net
Haemophilia: Causes and advancements in treatment that you should know - Hindustan Times
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - The New England Journal of Medicine
Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence - Nature
Etranacogene Dezaparvovec Shows Durable Activity and Reduced Consumption of Factor IX in Hemophilia B After 3 Years - CGTLive®
Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX - American Heart Association Journals
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - The New England Journal of Medicine
Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice - Gene Therapy - Nature
Plasma factor IX: The tip of the iceberg? - Sidonio - 2021 - Haemophilia - Wiley Online Library
Personal Story: Carrie - Centers for Disease Control and Prevention | CDC (.gov)
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial - The Lancet
Association Between Hepatic Triglyceride Content and Coagulation Factors: - American Heart Association Journals
Intellia opts out of hemophilia B gene editing work with Regeneron - Fierce Biotech
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response - Nature
The Function of extravascular coagulation factor IX in haemostasis - Mann - 2021 - Haemophilia - Wiley Online Library
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua - Wiley Online Library
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark - Mynewsdesk
ASH: CSL, uniQure's gene therapy Hemgenix shows durable protection in hemophilia B - Fierce Pharma
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis - American Heart Association Journals
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua - Wiley Online Library
Pfizer: Beqvez Gene Therapy Decreases Bleeding Rates in Hemophilia B Patients - 2 Minute Medicine
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B - Business Wire
Factor IX Deficiency and Prolonged Bleeding Time - The New England Journal of Medicine
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity - Wiley Online Library
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors - The New England Journal of Medicine
In Vivo Demonstration in Humans That Large Postprandial Triglyceride-Rich Lipoproteins Activate Coagulation Factor VII Through the Intrinsic Coagulation Pathway - American Heart Association Journals
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen - Wiley Online Library
Gene Therapy Helps Patients with Hemophilia - National Institutes of Health (NIH) | (.gov)
Increased mortality of COVID-19 infected diabetes patients: role of furin proteases | International Journal of Obesity - Nature
India’s first gene therapy offers new hope for haemophilia patients - The New Indian Express
Haemophilia B Due to a De Novo Insertion of a Human-Specific Alu Subfamily Member within the Coding Region of the Factor IX Gene - Nature
Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats - Nature
Rebinyn Approval for Hemophilia B Expanded to Include Routine Prophylaxis - Medical Professionals Reference
Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria - Nature
Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts - Nature
Emicizumab Prophylaxis in Hemophilia A with Inhibitors - The New England Journal of Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'factor ix'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
factpr ix,   factor iz,   factr ix,   facto rix,   facyor ix,   factor iix,   ffactor ix,   factot ix,   factor ic,   fctor ix,   fsctor ix,   gactor ix,   factor i,   afctor ix,   faxtor ix,   favtor ix,   fator ix,   factor ixx,   facto ix,   facttor ix,   factoor ix,   faactor ix,   facctor ix,   facor ix,   factir ix,   factoe ix,   factori x,   fatcor ix,   facotr ix,   factor ix,   facter ix,   facror ix,   factorr ix,   factro ix,   actor ix,   factor ox,   factor x,   factor ux,   factorix,   factor xi,   fcator ix,   dactor ix
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z